This site is intended for Healthcare professionals only.

Not received any observation from USFDA audit: Claris Lifesciences


Not received any observation from USFDA audit: Claris Lifesciences

New Delhi: Claris Lifesciences underwent an audit by the USFDA for pharmacovigilance in the last week of May and has not received any observation.

“Claris Lifesciences along with its wholly-owned subsidiary Claris Injectables Ltd announced today that it underwent a successful USFDA Pharmacovigilance (PV) audit from May 29-31 with no observation (i483s),” the company said in a BSE filing.

The company shares were trading up by 4.34 per cent at Rs. 341.25 on the BSE.



Source: PTI
0 comment(s) on Not received any observation from USFDA audit: Claris Lifesciences

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted